Conditions: Asthma Coronary Artery Disease Pulmonary Disease, Chronic Obstructive
Keywords: regadenoson CVT 3146 asthma coronary artery disease pulmonary disease, chronic obstructive
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1009
Healthy volunteers: no

Brief summary:
This study is intended to determine the safety and tolerance of regadenoson in subjects with asthma or chronic obstructive pulmonary disease.

Detailed description:

Arms:
arm 1: Matching intravenous (IV) bolus injection, subjects with Asthma arm 2: 0.4mg / 5mL intravenous bolus injection, subjects with Asthma arm 3: Matching intravenous bolus injection, subjects with Chronic Obstructive Pulmonary Disease (COPD) arm 4: 0.4mg / 5mL intravenous bolus injection, subjects with Chronic Obstructive Pulmonary Disease (COPD)

Interventions: intervention 1: Regadenoson intervention 2: Placebo
Intervention descriptions: intervention 1: IV intervention 2: IV

Protocol document: